Cellectar Biosciences Announces 2nd Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- Houthi attack on Saudi airport kills 12, over 300 wounded, authorities say
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
Cellectar Biosciences (CLRB) Reports Q2 Loss of $0.30/Share
August 12, 2015 4:51 PM EDTCellectar Biosciences (NASDAQ: CLRB) reported Q2 EPS of ($0.30), versus ($0.73) reported last year.
For earnings history and earnings-related data on Cellectar Biosciences (CLRB) click here.
... More


